IMCRImmunocore Holdings plc

Nasdaq immunocore.com


$ 33.50 $ -0.40 (-1.19 %)    

Friday, 28-Jun-2024 12:11:32 EDT
QQQ $ 481.97 $ -1.42 (-0.29 %)
DIA $ 391.99 $ -1.05 (-0.27 %)
SPY $ 546.65 $ -0.99 (-0.18 %)
TLT $ 92.50 $ -1.23 (-1.31 %)
GLD $ 215.41 $ -0.53 (-0.25 %)
$ 33.78
$ 33.90
$ 0.00 x 0
$ 0.00 x 0
$ 33.17 - $ 34.00
$ 33.32 - $ 76.98
393,258
na
1.68B
$ 0.63
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-immunocore-hldgs-maintains-100-price-target

HC Wainwright & Co. analyst Patrick Trucchio reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $100 pri...

 needham-reiterates-buy-on-immunocore-hldgs-maintains-81-price-target

Needham analyst Gil Blum reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $81 price target.

 hc-wainwright--co-reiterates-buy-on-immunocore-hldgs-maintains-100-price-target

HC Wainwright & Co. analyst Patrick Trucchio reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $100 pri...

 needham-reiterates-buy-on-immunocore-hldgs-maintains-81-price-target

Needham analyst Gil Blum reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $81 price target.

 hc-wainwright--co-reiterates-buy-on-immunocore-hldgs-maintains-100-price-target

HC Wainwright & Co. analyst Patrick Trucchio reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $100 pri...

 needham-reiterates-buy-on-immunocore-hldgs-maintains-81-price-target

Needham analyst Gil Blum reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $81 price target.

 mizuho-maintains-buy-on-immunocore-hldgs-lowers-price-target-to-88

Mizuho analyst Graig Suvannavejh maintains Immunocore Hldgs (NASDAQ:IMCR) with a Buy and lowers the price target from $90 to...

 canaccord-genuity-maintains-hold-on-immunocore-hldgs-raises-price-target-to-67

Canaccord Genuity analyst Bill Maughan maintains Immunocore Hldgs (NASDAQ:IMCR) with a Hold and raises the price target from...

 hc-wainwright--co-maintains-buy-on-immunocore-hldgs-raises-price-target-to-100

HC Wainwright & Co. analyst Patrick Trucchio maintains Immunocore Hldgs (NASDAQ:IMCR) with a Buy and raises the price ta...

 needham-reiterates-buy-on-immunocore-hldgs-maintains-81-price-target

Needham analyst Gil Blum reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $81 price target.

 leerink-partners-initiates-coverage-on-immunocore-hldgs-with-outperform-rating-announces-price-target-of-74

Leerink Partners analyst Jonathan Chang initiates coverage on Immunocore Hldgs (NASDAQ:IMCR) with a Outperform rating and an...

 guggenheim-reiterates-buy-on-immunocore-hldgs-maintains-92-price-target

Guggenheim analyst Michael Schmidt reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $92 price target.